Atomo and BBI to Develop Test Platform

Atomo Diagnostics and BBI Solutions to Develop Test Platform

Medical technology developer Atomo Diagnostics and diagnostic company BBI Solutions are working together to commercialise the AtomoRapid^tm hand-held blood test device that will offer an easy to use solution for medical practitioners in doctors’ surgeries, outreach clinics and patients’ homes.

"AtomoRapid represents a new standard in usability for lateral flow testing and perfectly complements the product offerings and focus on innovative solutions that BBI is known for. BBI is proud to work with the Atomo team to bring exciting new products to market”, said the company’s Chief Commercial Officer Leigh Thomas.  The agreement provides BBI Solutions with access to the Atomo platform to utilise across any number of OEM requests requiring blood sampling. 

Atomo’s CEO, Mr John Kelly, said, “We are extremely pleased to have BBI engaged in the global rollout out of AtomoRapid. We view their commitment to AtomoRapid™ as a validation of the market friendly solutions being developed by Atomo to address unmet needs in the healthcare industry.” It is the first of a range of products to be launched by the Sydney-Australia based company

Part of the Alere group, BBI supplies of diagnostic assay development and manufacturing products, critical reagents and technologies to the European and global diagnostic and pharmaceutical markets.